01.11.2020 • NewsAzelis

Azelis Boosts China Personal Care Footprint

Azelis has entered into an agreement to buy Bronson and Jacobs Hong Kong and its wholly owned subsidiary in Shanghai, China, from owner Ixom, an Australian chemicals and water treatment distributor. Financial terms were not disclosed.

Bronson and Jacobs China specializes in distributing personal care ingredients, primarily for skincare, and has offices in Hong Kong, Shanghai and Guangzhou, the latter location also housing a personal care laboratory.

The deal, said Azelis, strengthens its footprint in the China personal care market, allowing it to better serve several key multinational customers in the country. Growth in China is a prime strategic objective for the specialty chemicals distributor.

 It also follows the purchase in April of CosBond, a Chinese specialty chemicals and food ingredients distributor that is headquartered in Hong Kong with offices and warehouses in Shanghai, Guangzhou and Beijing.

“The portfolio of Bronson and Jacobs China is highly complementary to CosBond’s and Azelis’ and will enhance our lateral value chain in this segment,” said Laurent Nataf, CEO & president of Azelis Asia Pacific. “Customers of both organizations will benefit from improved product range and access to additional principals.”

The transaction is expected to close within two months.

Azelis has agreed to buy Bronson and Jacobs Hong Kong and its wholly owned...
Azelis has agreed to buy Bronson and Jacobs Hong Kong and its wholly owned subsidiary in Shanghai, China. Bronson and Jacobs China specializes in distributing personal care ingredients, primarily for skincare, and has offices in Hong Kong, Shanghai and Guangzhou. (c) Azelis

Company

Logo:

Azelis Corporate Services NV

12 box 6, Posthofbrug
2600 Antwerpen
Belgium

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.